ATE92320T1 - Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe. - Google Patents

Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.

Info

Publication number
ATE92320T1
ATE92320T1 AT90108858T AT90108858T ATE92320T1 AT E92320 T1 ATE92320 T1 AT E92320T1 AT 90108858 T AT90108858 T AT 90108858T AT 90108858 T AT90108858 T AT 90108858T AT E92320 T1 ATE92320 T1 AT E92320T1
Authority
AT
Austria
Prior art keywords
thioacetazone
ethambutol
applicable
active substances
acid hydrazide
Prior art date
Application number
AT90108858T
Other languages
German (de)
English (en)
Inventor
Klaus Juergen Dr Schaper
Joachim Prof Seydel
Original Assignee
Fatol Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fatol Arzneimittel Gmbh filed Critical Fatol Arzneimittel Gmbh
Application granted granted Critical
Publication of ATE92320T1 publication Critical patent/ATE92320T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT90108858T 1989-05-19 1990-05-11 Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe. ATE92320T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3916417A DE3916417A1 (de) 1989-05-19 1989-05-19 Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid als aktive wirkstoffe
EP90108858A EP0398165B1 (de) 1989-05-19 1990-05-11 Kombinationspräparate enthaltend Rifampicin und Thioacetazon sowie gegebenenfalls Isonicotinsäurehydrazid oder Ethambutol als aktive Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE92320T1 true ATE92320T1 (de) 1993-08-15

Family

ID=6381016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90108858T ATE92320T1 (de) 1989-05-19 1990-05-11 Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.

Country Status (4)

Country Link
US (1) US5104875A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0398165B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE92320T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3916417A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087547A1 (en) * 2001-04-27 2002-11-07 Lupin Limited An improved process for preparation of four-drug anti-tubercular fixed dose combination
RU2195937C1 (ru) * 2002-02-06 2003-01-10 НИИ молекулярной медицины ММА им. И.М.Сеченова Комбинированный противотуберкулезный препарат (ризобутол)
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
US7884097B2 (en) * 2003-09-05 2011-02-08 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
US20050249804A1 (en) * 2004-05-07 2005-11-10 Sapte Vinay R Stabilized short-course chemotherapy (SCC) anti-tuberculosis drug compositions
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
RU2627611C2 (ru) * 2015-10-30 2017-08-09 Акционерное общество "Фармасинтез" (АО "Фармасинтез") Противотуберкулезная фармацевтическая композиция, содержащая тиоацетазон
WO2018035183A1 (en) * 2016-08-16 2018-02-22 University Of Rochester Pharmaceutical composition containing polymyxin b/trimethoprim based therapeutics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751567A (en) * 1969-03-24 1973-08-07 Ciba Geigy Corp Synergistic antibiotics

Also Published As

Publication number Publication date
DE59002154D1 (de) 1993-09-09
EP0398165B1 (de) 1993-08-04
EP0398165A1 (de) 1990-11-22
DE3916417C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-08-08
DE3916417A1 (de) 1990-11-22
US5104875A (en) 1992-04-14

Similar Documents

Publication Publication Date Title
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
PT87086A (pt) Active specific immune suppression
NO951740D0 (no) Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse
EA199900553A1 (ru) Чрескожная терапевтическая система
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
ATE92320T1 (de) Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.
GB8824869D0 (en) Synthetic antibody
ATE34077T1 (de) Hautbehandlungsmittel.
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
ATE70447T1 (de) Transdermal anwendbare pharmazeutische zubereitungen mit sterolen und/oder spiroketalinen.
NO890046D0 (no) Disubstituerte pyridiner.
ATE7107T1 (de) Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln.
DK0671909T3 (da) Syndecanstimulering af cellulær differentiering
FI911269A7 (fi) Menetelmä ja koostumus aktiivisten aineiden lisääntyneen pitoisuuden aikaansaamiseksi iholla iontoforeesin avulla
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
EE03170B1 (et) Perifeerse vere mononukleaarsete rakkude tsütotoksilise aktiivsuse stimuleerimine IL-10 abil
KR910006478A (ko) 인체 트립타제 유사 단백질
ATE171070T1 (de) Neue verwendung von equisetum
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
IE811612L (en) Thiazoles
ATE147269T1 (de) Behandlung von männerunfruchtbarkeit
DE59701514D1 (de) Verfahren zur bestimmung der phototoxizität und/oder photosensibilität von stoffen oder stoffgemischen sowie dessen verwendung
ATE149166T1 (de) Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikämie und gicht

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee